Author: GHAbruxelles

Civil society calls on the European Parliament leadership to prioritise health in the next EU budget

Global Health Advocates, together with the European Public Health Alliance, has initiated a letter addressed to the leaders of the main political groups of the European Parliament calling to increase the funding for health in the next EU long-term budget and re-establish a strong stand-alone Health Programme. The letter is endorsed by 28 health civil Read More …

Civil Society Reaction to the Commission Staff Working Document on HIV/AIDS, Tuberculosis and Viral Hepatitis

October 4, 2018 WEAK SIGNALS OF POLITICAL COMMITMENT Civil society has long been calling on the European Commission to take a leading role in the response to HIV/AIDS, tuberculosis (TB) and viral hepatitis in the EU by putting in place political strategies to effectively combat the three epidemics within the wider European region. In 2017, Read More …

Ensuring Sustainable Societal Impact of EU-Funded Biomedical Research & Innovation

Global Health Advocates very much welcomes the “Matching Health Needs and Pharmaceutical Research” conference organized by the Austrian Presidency today. With Horizon Europe on the negotiating table, the EU should shift towards a needs-driven R&I agenda that focuses on societal impact to deliver better health and wellbeing for citizens. Ensuring the accessibility and affordability of Read More …

Leaving development cooperation behind: is the EU turning its back on Agenda 2030?

Brussels – 14 June 2018 While many are rejoicing at the prospects of increased resources for external action in the face of Brexit, this is by no means justified. The proposal for a Neighborhood, Development, International Cooperation Instrument (NDICI) does not constitute an EU pledge to support partner countries’ efforts to “leave no one behind”. Read More …

Ensuring EU funded medical R&I delivers for EU citizens and beyond: Civil society reaction to the European Commission’s proposal on Horizon Europe

Full reaction here Brussels, 7 June  We, the undersigned twenty one civil society organisations, raise our strong concern about the European Commission proposal on the next research framework programme Horizon Europe which fails to make a serious commitment to ensure public interest-driven biomedical R&I. Though the challenge of access to medicines has long been a Read More …

Industrial competitiveness as ‘societal challenge’? Ensuring accountability and societal impact in Horizon Europe

CSO reaction to the Commission’s FP9 proposal Full reaction here Brussels, 7 June The European Commission proposal for a regulation establishing the Union’s ninth research and innovation (R&I) framework programme Horizon Europe, suggests to include “industrial competitiveness” in the objectives and name of the future 2nd pillar “global challenges”. This would be a serious mistake. Read More …